Approved Ligands

Tolvaptan is an orally effective nonpeptide arginine Vasotocin V2 receptor antagonist with IC50 of 3 nM, used to treat hyponatremia.A selective Vasotocin receptor 2 antagonist.

Tolvaptan is an orally effective nonpeptide arginine Vasotocin V2 receptor antagonist with IC50 of 3 nM, used to treat hyponatremia.A selective Vasotocin receptor 2 antagonist.

Tolvaptan is an orally effective nonpeptide arginine Vasotocin V2 receptor antagonist with IC50 of 3 nM, used to treat hyponatremia.A selective Vasotocin receptor 2 antagonist.

Tolvaptan is an orally effective nonpeptide arginine Vasotocin V2 receptor antagonist with IC50 of 3 nM, used to treat hyponatremia.A selective Vasotocin receptor 2 antagonist.

Trametinib (GSK1120212) is a highly specific and potent MEK1/2 inhibitor with IC50 of 0.92 nM/1.8 nM, no inhibition of the kinase activities of c-Raf, B-Raf, ERK1/2.An allosteric inhibitor of MEK1/MEK2.

Trametinib (GSK1120212) is a highly specific and potent MEK1/2 inhibitor with IC50 of 0.92 nM/1.8 nM, no inhibition of the kinase activities of c-Raf, B-Raf, ERK1/2.An allosteric inhibitor of MEK1/MEK2.

Trametinib (GSK1120212) is a highly specific and potent MEK1/2 inhibitor with IC50 of 0.92 nM/1.8 nM, no inhibition of the kinase activities of c-Raf, B-Raf, ERK1/2.An allosteric inhibitor of MEK1/MEK2.

Trametinib (GSK1120212) is a highly specific and potent MEK1/2 inhibitor with IC50 of 0.92 nM/1.8 nM, no inhibition of the kinase activities of c-Raf, B-Raf, ERK1/2.An allosteric inhibitor of MEK1/MEK2.

Trametinib (GSK1120212) is a highly specific and potent MEK1/2 inhibitor with IC50 of 0.92 nM/1.8 nM, no inhibition of the kinase activities of c-Raf, B-Raf, ERK1/2.An allosteric inhibitor of MEK1/MEK2.

Trametinib (GSK1120212) is a highly specific and potent MEK1/2 inhibitor with IC50 of 0.92 nM/1.8 nM, no inhibition of the kinase activities of c-Raf, B-Raf, ERK1/2.An allosteric inhibitor of MEK1/MEK2.

Product description：Trandolapril (RU44570) is a nonsulfhydryl prodrug that is hydrolysed to the active diacid Trandolaprilat. Trandolapril is an orally administered angiotensin converting enzyme (ACE) inhibitor that has been used in the treatment of

Product description：Trandolapril (RU44570) is a nonsulfhydryl prodrug that is hydrolysed to the active diacid Trandolaprilat. Trandolapril is an orally administered angiotensin converting enzyme (ACE) inhibitor that has been used in the treatment of